Scindeks Assistant SCIndeks Assistant: Journal Management System
Vol. 82 No. 08 (2025)
Vol. 82 No. 08 (2025)

Diagnostic criteria and treatment of patients with short bowel syndrome – consensus statements of the National Society for Clinical Nutrition of Serbia (NUPENS)

DOI: 10.2298/VSP250307055B
Mihailo Bezmarević
Military Medical Academy, Clinic for General Surgery, Department of Hepatobiliary and Pancreatic Surgery, Belgrade, Serbia
Ivan Palibrk
University of Belgrade, Faculty of Medicine, Belgrade, Serbia; §University Clinical Center of Serbia, Hospital for Digestive Surgery, Department of Anaesthesiology and Intensive Care, Belgrade, Serbia
Mirjana Stojšić
University of Novi Sad, Faculty of Medicine, Novi Sad, Serbia
Natalija Vuković
University Clinical Center Niš, Clinic for Anesthesiology, Reanimation, and Intensive Care, Niš, Serbia
Marija Djukanović
University of Belgrade, Faculty of Medicine, Belgrade, Serbia; §University Clinical Center of Serbia, Hospital for Digestive Surgery, Department of Anaesthesiology and Intensive Care, Belgrade, Serbia
Danijela Jovanović
University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia; ‡‡University Clinical Center Kragujevac, Center for Anesthesiology, Reanimatology, and Intensive Care, Department of Surgery, Kragujevac, Serbia
Igor Krdžić
Euromedik Hospital, Department of General and Abdominal Surgery, Belgrade, Serbia
Dušica Simić
University of Belgrade, Faculty of Medicine, Belgrade, Serbia
Ivan Pantić
Military Medical Academy, Clinic for General Surgery, Department of Hepatobiliary and Pancreatic Surgery, Belgrade, Serbia
Marina Panišić Šekeljić
Military Medical Academy, Clinic for General Surgery, Department of Hepatobiliary and Pancreatic Surgery, Belgrade, Serbia
PDF

Published

2025-08-27

Section

Current Topic

How to Cite

1.
Bezmarević M, Palibrk I, Stojšić M, Vuković N, Djukanović M, Jovanović D, et al. Diagnostic criteria and treatment of patients with short bowel syndrome – consensus statements of the National Society for Clinical Nutrition of Serbia (NUPENS). Vojnosanit Pregl [Internet]. 2025 Aug. 27 [cited 2026 Jul. 12];82(08). Available from: https://asistent.ceon.rs/index.php/vsp/article/view/57335
ACS APA ABNT Chicago Harvard IEEE Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Keywords

diagnosis;
enteral nutrition;
intestinal failure;
parenteral nutrition;
parenteral nutrition, home;
quality of life;
short bowel syndrome.
DOI: 10.2298/VSP250307055B

References

Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al. Home artificial nutrition & chronic intestinal failure special interest group of ESPEN. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr 2016; 35(2): 247–307. Erratum in: Clin Nutr 2017; 36(2): 619.

Pironi L, Cuerda C, Jeppesen PB, Joly F, Jonkers C, Krznarić Ž, et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clin Nutr 2023; 42(10): 1940–2021.

Pironi L, Boeykens K, Bozzetti F, Joly F, Klek S, Lal S, et al. ES-PEN guideline on home parenteral nutrition. Clin Nutr 2020; 39(6): 1645–66.

Pironi L, Arends J, Baxter J, Bozzetti F, Peláez RB, Cuerda C, et al. ESPEN endorsed recommendations. Definition and classi-fication of intestinal failure in adults. Clin Nutr 2015; 34(20): 171–80.

Brandt CF, Hvistendahl M, Naimi RM, Tribler S, Staun M, Brøbech P, et al. Home parenteral nutrition in adult patients with chronic intestinal failure: the evolution over 4 decades in a tertiary referral center. JPEN J Parenter Enter Nutr 2017; 41(7): 1178–87.

Orphanet. The portal for rare diseases and orphan drugs [Inter-net]. France: Orphanet; 2025 [cited 2024 April 20; accessed 2025 May 19]. Available from: https://www.orpha.

net/consor/cgi-bin/index.php

ICD-11 for Mortality and Morbidity Statistics. DA96.05 Intestinal failure [Internet]. 2025; [cited 2022 Aug 17; accessed 2025 May 19]. Available from: https://icd.who.int/dev11/l-m/en#/

http://id.who.int/icd/entity/778202494

Bering J, DiBaise JK. Short bowel syndrome in adults. Am J Gastroenterol 2022; 117(6): 876–83.

Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterol-ogy 2003; 124(4): 1111–34.

ICD-11 for Mortality and Morbidity Statistics. DA 96.04 Short bowel syndrome [Internet]. 2025; [cited 2022 Nov 16; ac-cessed 2025 May 19]. Available from: https://icd.who.int/

browse/2025-01/mms/en#780637678

Lauro A, Lacaille F. Short bowel syndrome in children and adults: from rehabilitation to transplantation. Expert Rev Gastroenterol Hepatol 2019; 13(1): 55–70.

NUPENS. National Association for Clinical Nutrition of Ser-bia [Internet]. Belgrade: NUPENS; 2025 [accessed 2025 May 20]. Available from: https://www.nupens.org/ (Serbian)

Pironi L. Definitions of intestinal failure and the short bowel syndrome. Best Pract Res Clin Gastroenterol 2016; 30(2): 173–85.

Fung JJ. William Hunter Harridge lecture: The changing face of short-gut syndrome management. Am J Surg 2017; 213(3): 448–51.

Lauro A, Cirocchi R, Cautero N, Dazzi A, Pironi D, Di Matteo FM, et al. Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and a systematic review of literature. G Chir 2017; 38(4): 163–75.

Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut 1991; 32(11): 1321–3.

Pironi L, Konrad D, Brandt C, Joly F, Wanten G, Agostini F, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey. Clin Nutr 2018; 37(2): 728–38.

Lezo A, Diamanti A, Marinier EM, Tabbers M, Guz-Mark A, Gandullia P, et al. Chronic intestinal failure in children: an in-ternational multicenter cross-sectional survey. Nutrients 2022; 14(9): 1889.

Pironi L, Steiger E, Joly F, Jeppesen PB, Wanten G, Sasdelli AS, et al. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multi-center survey. Clin Nutr ESPEN 2021; 45: 433–41.

Jeppesen PB. Short bowel syndrome - characterisation of an or-phan condition with many phenotypes. Expert Opin Orphan Drugs 2013; 1(7): 515–25.

Messing B, Crenn P, Beau P, Boutron-Ruault MC, Rambaud JC, Matuchansky C. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999; 117(5): 1043–50.

Amiot A, Messing B, Corcos O, Panis Y, Joly F. Determinants of home parenteral nutrition dependence and survival of 268 pa-tients with nonmalignant short bowel syndrome. Clin Nutr 2013; 32(3): 368–74.

Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intes-tinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr 2012; 31(6): 831–45.

Baxter JP, Fayers PM, McKinlay AW. A review of the quality of life of adult patients treated with long-term parenteral nutri-tion. Clin Nutr 2006; 25(4): 543–53.

Comerlato PH, Stefani J, Viana LV. Mortality and overall and specific infection complication rates in patients who receive parenteral nutrition: systematic review and meta-analysis with trial sequential analysis. Am J Clin Nutr 2021; 114(4): 1535–45.

Kaufman SS, Avitzur Y, Beath SV, Ceulemans LJ, Gondolesi GE, Mazariegos GV, et al. New insights into the indications for in-testinal transplantation: consensus in the year 2019. Trans-plantation 2020; 104(5): 937–46.

Messing B, Pigot F, Rongier M, Morin MC, Ndeïndoum U, Ram-baud JC. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 1991; 100(6): 1502–8.

Austin K, Bonnes S, Daniel H. Controversy in nutrition recom-mendations for short bowel syndrome: how type of SBS im-pacts response. Curr Gastroenterol Rep 2019; 21(12): 64.

Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ. Oral salt supplements to compensate for jejunostomy losses: com-parison of sodium chloride capsules, glucose electrolyte solu-tion, and glucose polymer electrolyte solution. Gut 1992; 33(6): 759–61.

McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986; 91(1): 25–33.

Levy E, Frileux P, Sandrucci S, Ollivier JM, Masini JP, Cosnes J, et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg 1988; 75(6): 549–53.

Cosnes J, Evard D, Beaugerie L, Gendre JP, Le Quintrec Y. Im-provement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition 1992; 8(6): 406–11.

Sladen GE, Dawson AM. Interrelationships between the ab-sorptions of glucose, sodium and water by the normal human jejunum. Clin Sci 1969; 36(1): 119–32.

Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998; 43(4): 478–83.

Jeppesen PB, Hartmann B, Hansen BS, Thulesen J, Holst JJ, Mortensen PB. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999; 45(4): 559–63.

Nightingale JM, Kamm MA, van der Sijp JR, Ghatei MA, Bloom SR, Lennard-Jones JE. Gastrointestinal hormones in short bow-el syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 1996; 39(2): 267–72.

Nightingale JM, Lennard-Jones JE, Walker ER, Farthing MJ. Jeju-nal efflux in short bowel syndrome. Lancet 1990; 336(8718): 765–8.

Williams NS, Evans P, King RF. Gastric acid secretion and gas-trin production in the short bowel syndrome. Gut 1985; 26(9): 914–9.

Go VL, Poley JR, Hofmann AF, Summerskill WH. Disturbances in fat digestion induced by acidic jejunal pH due to gastric hy-persecretion in man. Gastroenterology 1970; 58(5): 638–46.

Dueno MI, Bai JC, Santangelo WC, Krejs GJ. Effect of somato-statin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci 1987; 32(10): 1092–6.

Fuessl HS, Carolan G, Williams G, Bloom SR. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987; 36(2): 101–7.

Ladefoged K, Christensen KC, Hegnhøj J, Jarnum S. Effect of a long acting somatostatin analogue SMS 201-995 on jejunos-tomy effluents in patients with severe short bowel syndrome. Gut 1989; 30(7): 943–9.

Remington M, Malagelada JR, Zinsmeister A, Fleming CR. Ab-normalities in gastrointestinal motor activity in patients with short bowels: effect of a synthetic opiate. Gastroenterology 1983; 85(3): 629–36.

Cole CR, Ziegler TR. Small bowel bacterial overgrowth: a nega-tive factor in gut adaptation in pediatric SBS. Curr Gastroen-terol Rep 2007; 9(6): 456–62.

Ziegler TR, Cole CR. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure. Curr Gas-troenterol Rep 2007; 9(6): 463–7.

Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, et al. Teduglutide (ALX-0600), a dipeptidyl pepti-dase IV resistant glucagonlike peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005; 54(9): 1224–31.

Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid re-quirements in patients with short bowel syndrome. Gut 2011; 60(7): 902–14.

O’Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Mess-ing B. Safety and efficacy of teduglutide after 52 Weeks of treatment in patients with short bowel syndrome intestinal failure. Clin Gastroenterol Hepatol 2013; 11(7): 815–23. e1–3.

Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'Keefe SJ, et al. Teduglutide reduces need for parenteral sup-port among patients with short bowel syndrome with intesti-nal failure. Gastroenterology 2012; 143(6): 1473–81. e3.

Naberhuis JK, Tappenden KA. Teduglutide for safe reduction of parenteral nutrient and/or fluid requirements in adults: A systematic review. JPEN J Parenter Enteral Nutr 2016; 40(8): 1096–105.

Joly F, Zhang P, Allard JP, Genestin E, Gondolesi G, Jeppesen PB, et al. Long-term safety analysis of teduglutide treatment in adult patients with short bowel syndrome and intestinal fail-ure. Clin Nutr ESPEN 2023; 54: 501.

Joly F, Jezerski D, Pape UF, Crivelli A, Hütterer E, Bergoin C, et al. Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey. Clin Nutr 2025; 47: 54–67.

Schwartz LK, O’Keefe SJ, Fujioka K, Gabe SM, Lamprecht G. Pape UF, et al. Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome. Clin Transl Gastroenterol 2016; 7(2): e142.

Adaba F, Uppara M, Iqbal F, Mallappa S, Vaizey CJ, Gabe SM, et al. Chronic cholestasis in patients on parenteral nutrition: the influence of restoring bowel continuity after mesenteric infarction. Eur J Clin Nutr 2016; 70(2): 189–93.